16:38 EDT Karyopharm (KPTI) files $400M mixed securities shelf
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KPTI:
- KPTI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Karyopharm price target raised to $16 from $8 at Piper Sandler
- Karyopharm price target lowered to $16 from $23 at RBC Capital
- Karyopharm price target lowered to $8 from $12 at Piper Sandler
- Karyopharm Strengthens Liquidity With New Equity Financing